Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kimberley Ashdown"'
Autor:
Arthur R Bradwell, Kimberley Ashdown, Carla Rue, John Delamere, Owen D Thomas, Samuel J E Lucas, Alex D Wright, Stephen J Harris, Stephen D Myers
Publikováno v:
BMJ Open Sport & Exercise Medicine, Vol 4, Iss 1 (2018)
Objective To assess whether acetazolamide (Az), used prophylactically for acute mountain sickness (AMS), alters exercise capacity at high altitude.Methods Az (500 mg daily) or placebo was administered to 20 healthy adults (aged 36±20 years, range 21
Externí odkaz:
https://doaj.org/article/add0e9ac9d6641849b002fa349f28f2b
Autor:
John Delamere, Brian G. Johnson, Susie B. Bradwell, Will Malein, Kimberley Ashdown, Arthur R. Bradwell, Mark Edsell, Alex D. Wright, Kelsey E. Joyce, Amy Fountain, Carla A. Rue, Stephen D. Myers, Charles Newman, Patrick Cadigan, Christopher T. Lewis, Owen Thomas, Samuel J. E. Lucas, Christopher H.E. Imray, Fiona A. Myers, Alexander J. Clarke
Publikováno v:
Joyce, K E, Delamere, J, Bradwell, S, Myers, S D, Ashdown, K, Rue, C, Lucas, S J E, Thomas, O D, Fountain, A, Edsell, M, Myers, F, Malein, W, Imray, C, Clarke, A, Lewis, C T, Newman, C, Johnson, B, Cadigan, P, Wright, A & Bradwell, A 2020, ' Hypoxia is not the primary mechanism contributing to exercise-induced proteinuria ', BMJ Open Sport and Exercise Medicine, vol. 6, no. 1, e000662 . https://doi.org/10.1136/bmjsem-2019-000662
BMJ Open Sport — Exercise Medicine
BMJ Open Sport & Exercise Medicine, Vol 6, Iss 1 (2020)
BMJ Open Sport — Exercise Medicine
BMJ Open Sport & Exercise Medicine, Vol 6, Iss 1 (2020)
IntroductionProteinuria increases at altitude and with exercise, potentially as a result of hypoxia. Using urinary alpha-1 acid glycoprotein (α1-AGP) levels as a sensitive marker of proteinuria, we examined the impact of relative hypoxia due to high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e986db693808a349f1795a8917468b63
https://doi.org/10.1136/bmjsem-2019-000662
https://doi.org/10.1136/bmjsem-2019-000662
Autor:
John Delamere, Alex D. Wright, Stephen D. Myers, Owen Thomas, Carla A. Gallagher, Arthur R. Bradwell, Kimberley Ashdown, Stephen Harris, Samuel J. E. Lucas
Acetazolamide (Az) is widely used to prevent and treat the symptoms of acute mountain sickness (AMS) but whether it alters exercise capacity at high altitude is unclear. Az (250 mg twice daily) or placebo were administered to 20 healthy adults (age r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db9e97f8c73a0e41ccfafe7c5589b45d
Autor:
John Delamere, Carla A. Rue, Alex D. Wright, Stephen Harris, Arthur R. Bradwell, Kimberley Ashdown, Samuel J. E. Lucas, Owen Thomas, Stephen D. Myers
Publikováno v:
BMJ Open Sport — Exercise Medicine
ObjectiveTo assess whether acetazolamide (Az), used prophylactically for acute mountain sickness (AMS), alters exercise capacity at high altitude.MethodsAz (500 mg daily) or placebo was administered to 20 healthy adults (aged 36±20 years, range 21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d310ee17598fff9ed8770579c8a31451
https://doi.org/10.1136/bmjsem-2017-000302
https://doi.org/10.1136/bmjsem-2017-000302